CytoSorbents Corp. (CTSO)
6.01
+0.66
(+12.34%)
USD |
NASDAQ |
Oct 22, 16:00
5.71
-0.30
(-4.99%)
After-Hours: 05:38
CytoSorbents Gross Profit Margin (Quarterly) : 73.18% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 73.18% |
| March 31, 2026 | 69.16% |
| December 31, 2025 | 73.68% |
| September 30, 2025 | 70.28% |
| June 30, 2025 | 70.85% |
| March 31, 2025 | 71.13% |
| December 31, 2024 | 0.00% |
| September 30, 2024 | 61.02% |
| June 30, 2024 | 73.55% |
| March 31, 2024 | 76.46% |
| December 31, 2023 | 68.07% |
| September 30, 2023 | 63.64% |
| June 30, 2023 | 63.89% |
| March 31, 2023 | 57.73% |
| December 31, 2022 | 61.31% |
| September 30, 2022 | 44.60% |
| June 30, 2022 | 58.21% |
| March 31, 2022 | 73.79% |
| December 31, 2021 | 71.04% |
| September 30, 2021 | 74.77% |
| June 30, 2021 | 77.46% |
| March 31, 2021 | 74.04% |
| December 31, 2020 | 78.86% |
| September 30, 2020 | 72.59% |
| June 30, 2020 | 66.82% |
| Date | Value |
|---|---|
| March 31, 2020 | 72.61% |
| December 31, 2019 | 71.81% |
| September 30, 2019 | 72.17% |
| June 30, 2019 | 70.57% |
| March 31, 2019 | 66.51% |
| December 31, 2018 | 65.74% |
| September 30, 2018 | 64.26% |
| June 30, 2018 | 68.97% |
| March 31, 2018 | 68.17% |
| December 31, 2017 | 72.78% |
| September 30, 2017 | 60.34% |
| June 30, 2017 | 58.44% |
| March 31, 2017 | 59.71% |
| December 31, 2016 | 57.94% |
| September 30, 2016 | 60.03% |
| June 30, 2016 | 60.71% |
| March 31, 2016 | 54.73% |
| December 31, 2015 | 54.36% |
| September 30, 2015 | 52.46% |
| June 30, 2015 | 51.72% |
| March 31, 2015 | 57.89% |
| December 31, 2014 | 62.30% |
| September 30, 2014 | 59.06% |
| June 30, 2014 | 34.99% |
| March 31, 2014 | 37.62% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 57.05% |
| AngioDynamics, Inc. | 56.00% |
| Alphatec Holdings, Inc. | 62.90% |
| AtriCure, Inc. | 76.75% |
| Baxter International, Inc. | 33.55% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -325.8% |
| Return on Assets | -41.41% |
| Return on Invested Capital | -53.06% |
| Profit Margin (Quarterly) | -45.85% |
| Operating Margin (Quarterly) | -23.92% |
| Return on Net Operating Assets | -53.89% |